Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 307, Issue 10, 2014, Pages G968-G978

  Hayashi, Shusaku ^a   Hamada, Takayuki ^a   Zaidi, Syed Faisal ^a   Oshiro, Momoe ^a   Lee, Jaemin ^a   Yamamoto, Takeshi ^a   Ishii, Yoko ^a   Sasahara, Masakiyo ^a   Kadowaki, Makoto ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

CD4 T cells; Dextran sulfate sodium induced colitis; 7 nicotinic acetylcholine receptor

Indexed keywords

AZOXYMETHANE; BUNGAROTOXIN RECEPTOR; DEXTRAN SULFATE; INTERLEUKIN 6; MESSENGER RNA; MICRORNA 21; NICOTINE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; AUTACOID; CHRNA7 PROTEIN, MOUSE; GASTROINTESTINAL AGENT; INTERLEUKIN-6, MOUSE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ACUTE DISEASE; AGONISTS; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; CHRONIC DISEASE; COLON; COLONIC NEOPLASMS; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; SEVERITY OF ILLNESS INDEX; TIME;

ACUTE DISEASE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COLITIS; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GASTROINTESTINAL AGENTS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MICE, INBRED BALB C; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922392868     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00346.2013     Document Type: Article

References (54)

1. Alsharari SD, Akbarali HI, Abdullah RA, Shahab O, Auttachoat W, Ferreira GA, White KL, Lichtman AH, Cabral GA, Damaj MI. Novel insights on the effect of nicotine in a murine colitis model. J Pharmacol Exp Ther 344: 207-217, 2013.
2. Andersson U, Tracey KJ. Reflex principles of immunological homeostasis. Annu Rev Immunol 30: 313-315, 2012.
3. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640, 2007.
4. Birrenbach T, Böcker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10: 848-859, 2004.
5. Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke T, Bateman T, Nebelsiek T, Lundgren-May T, Canli O, Schwitalla S, Matthews V, Schmid RM, Kirchner T, Arkan MC, Ernst M, Greten FR. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15: 91-102, 2009.
6. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 144: 36-49, 2013.
7. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462, 2000.
8. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249, 1993.
9. Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 21: 757-768, 2000.
10. Coussens LM, Werb Z. Inflammation and cancer. Nature 420: 860-86, 2002.
11. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 8: 844-851, 2005.
12. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107: 1643-1652, 1994.
13. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535, 2001.
14. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Büchler MW. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62: 240-248, 2000.
15. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998.
16. Fujii YX, Fujigaya H, Moriwaki Y, Misawa H, Kasahara T, GrandoSA, Kawashima K. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. J Neuroimmunol 189: 69-74, 2007.
17. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131: 1122- 1130, 2006.
18. Ghia JE, Blennerhassett P, El-Sharkawy RT, Collins SM. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am J Physiol Gastrointest Liver Physiol 293: G711-G718, 2007.
19. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296, 2004.
20. Grivennikov S, Karin E, Terzi´c J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L, Karin M. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113, 2009.
21. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, cancer. Cell 140: 883-899, 2010.
22. Heikkilä K, Ebrahim S, Lawlor DA. Systemic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 44: 937-945, 2008.
23. Hilsden RJ, Hodgins DC, Timmer A, Sutherland LR. Helping patients with Crohn's disease quit smoking. Am J Gastroenterol 95: 352-358, 2000.
24. Ito R, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, Imanishi J, Kita M, Ueda Y, Iwakura Y, Kataoka K, Okanoue T, Mazda O. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol 146: 330-338, 2006.
25. Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, Imanishi J, Iwakura Y, Okanoue T, Yoshikawa T, Kataoka K, Mazda O. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 377: 12-16, 2008.
26. Kageyama-Yahara N, Suehiro Y, Yamamoto T, Kadowaki M. IgEinduced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. Biochem Biophys Res Commun 377: 321-325, 2008.
27. Kawahara R, Yasuda M, Hashimura H, Amagase K, Kato S, Takeuchi K. Activation of α7 nicotinic acetylcholine receptors ameliorates indomethacin-induced small intestinal ulceration in mice. Eur J Pharmacol 650: 411-417, 2011.
28. Kawashima K, Yoshikawa K, Fujii YX, Moriwaki Y, Misawa H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci 80: 2314-2319, 2007.
29. Kishimoto T. Interleukin-6: from basic science to medicin-40 years in immunology. Annu Rev Immunol 23: 1-21, 2005.
30. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103: 1444-1451, 1992.
31. Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res 15: 24-27, 2005.
32. Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, Cvijic H, Ullmann AK, Stadler PF, Horn F. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330- 1333, 2007.
33. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474: 298-306, 2011.
34. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 454: 436-444, 2008.
35. McGrath J, McDonald JW, Macdonald JK. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev CD004722, 2004.
36. Melgar S, Karlsson A, Michaëlsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms. Am J Physiol Gastrointest Liver Physiol 288: G1328-G1338, 2005.
37. Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Yanagisawa R, Inoue K, Takano H, Satoh M, Yoshida N, Okanoue T, Yoshikawa T. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med 14: 191-196, 2004.
38. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990.
39. Oshima H, Oshima M. The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol 47: 97-106, 2012.
40. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118: 560-570, 2008.
41. Pullan RD, Rhodes J, Ganesh S, Mani V, MorrisJS, Williams GT, Newcombe RG, Russell MA. Transdermal nicotine for active ulcerative colitis. N Engl J Med 330: 811-815, 1994.
42. Putoczki TL, Thiem S, Loving A, Busuttil RA, Wilson NJ, Ziegler PK, Nguyen PM, Preaudet A, Farid R, Edwards KM, Boglev Y, Luwor RB, Jarnicki A, Horst D, Boussioutas A, Heath JK, Sieber OM, Pleines I, Kile BT, Nash A, Greten FR, McKenzie BS, Ernst M. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24: 257- 271, 2013.
43. Rosas-Ballina M, Olofsson PS, Ochani Valdés-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334: 98-101, 2011.
44. Sandborn WJ. Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results. Am J Gastroenterol 94: 1161-1171, 1999.
45. Schetter AJ, Nguyen GH, Bowman ED, Mathé EA, Yuen ST, Hawkes JE, Croce CM, Leung SY, Harris CC. Association of inflammationrelated and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 15: 5878-5887, 2009.
46. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene 26: 2799-2803, 2007.
47. Snoek SA, Verstege MI, van der Zanden EP, Deeks N, Bulmer DC, Skynner M, Lee K, Te Velde AA, Boeckxstaens GE, de Jonge WJ. Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol 160: 322-333, 2010.
48. Stolfi C, Rizzo A, Franzé E, Rotondi A, Fantini MC, Sarra M, Caruso R, Monteleone I, Sileri P, Franceschilli L, Caprioli F, Ferrero S, MacDonald TT, Pallone F, Monteleone G. Involvement of interleukin- 21 in the regulation of colitis-associated colon cancer. J Exp Med 208: 2279-2290, 2011.
49. Terzi´c J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 138: 2101-2114, 2010.
50. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 140: 1807-1816, 2011.
51. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388, 2003.
52. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, Brant SR, Chakravarti S, Kwon JH. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 135: 1624-1635, 2008.
53. Yamamoto T, Kodama T, Lee J, Utsunomiya N, Hayashi S, Sakamoto H, Kuramoto H, Kadowaki M. Anti-allergic role of cholinergic neuronal pathway via α7 nicotinic ACh receptors on mucosal mast cells in a murine food allergy model. PLoS One 9: e85888, 2014.
54. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809, 2009.